- Securities Registration: Employee Benefit Plan (S-8)
July 01 2010 - 3:29PM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission on July 01, 2010
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
INHIBITEX, INC.
(Exact Name of Registrant as Specified in Its Charter)
|
|
|
Delaware
|
|
74-2708737
|
(State or Other Jurisdiction of Incorporation or Organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
9005 Westside Parkway
|
|
|
Alpharetta, GA
|
|
30009
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Amended and Restated 2004 Stock Incentive Plan
(Full Title of the Plan)
|
|
|
Russell H. Plumb
|
|
Copy to:
|
President, Chief Executive Officer, Chief
|
|
David S. Rosenthal, Esq.
|
Financial Officer and Director
|
|
Dechert LLP
|
Inhibitex, Inc.
|
|
1095 Avenue of the Americas
|
9005 Westside Parkway
|
|
New York, New York 10036
|
Alpharetta, GA 30009
|
|
(212) 698-3500
|
(678) 746-1100
|
|
|
(Name and Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated
filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer
o
|
|
Accelerated filer
o
|
|
Non-accelerated filer
o
|
|
Smaller reporting company
þ
|
|
|
|
|
(Do not check if a smaller reporting company)
|
|
|
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount
|
|
|
|
Proposed Maximum
|
|
|
|
Proposed Maximum
|
|
|
|
Amount of
|
|
|
|
|
|
|
to be
|
|
|
|
Offering Price
|
|
|
|
Aggregate Offering
|
|
|
|
Registration
|
|
|
|
Title of Each Class of Securities To Be Registered
|
|
|
Registered (1)
|
|
|
|
Per Share (2)
|
|
|
|
Price (2)
|
|
|
|
Fee (2)
|
|
|
|
Common Stock, par value $.001 per share
|
|
|
3,800,000 shares
|
|
|
$
|
2.79
|
|
|
|
$
|
10,602,000
|
|
|
|
$
|
755.92
|
|
|
|
|
|
|
|
(1)
|
|
Pursuant to Rule 416 promulgated under the Securities Act of 1933,
as amended (the Act), this Registration Statement also covers
such additional securities as may become issuable to prevent
dilution resulting from stock splits, stock dividends and similar
transactions.
|
|
(2)
|
|
Estimated solely for the purpose of calculating the registration fee
pursuant to Rule 457(c) and (h) under the Act on the basis of $2.79
per share, the average of the high and low prices of the Common Stock
as quoted on the Nasdaq Capital Market on June 28, 2010.
|
TABLE OF CONTENTS
Statement Under General Instruction E
Registration of Additional Securities
This Registration Statement on Form S-8 is being filed for the purpose of registering an
additional 3,8000,000 shares of common stock, par value $.001 per share (the Common Stock), of
Inhibitex, Inc., a Delaware corporation (the Registrant), to be issued pursuant to the
Registrants Amended and Restated 2004 Stock Incentive Plan (the 2004 Plan).
Pursuant to General Instruction E to Form S-8, the Registrants Registration Statements on Form S-8
previously filed with the Securities and Exchange Commission (the Commission) relating to the
2004 Plan (Nos. 333-116446, 333-129122, and 333-147335) are incorporated herein by reference.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8. Exhibits.
The following exhibits are filed as part of this registration statement.
|
4.1
|
|
Amended and Restated 2004 Stock Incentive Plan
|
|
|
4.2
|
|
Non-Employee Directors Stock Option Agreement
|
|
|
4.3
|
|
Employee Stock Option Agreement
|
|
|
5.1
|
|
Opinion of Dechert LLP
|
|
|
23.1
|
|
Consent of Ernst & Young LLP
|
|
|
23.2
|
|
Consent of Dechert LLP (included in Exhibit 5.1)
|
|
|
24.1
|
|
Powers of Attorney (included on signature page).
|
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has
reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Alpharetta, State of Georgia, on July 01, 2010.
|
|
|
|
|
|
INHIBITEX, INC.
|
|
|
By:
|
/s/ Russell H. Plumb
|
|
|
|
Russell H. Plumb
|
|
|
|
President, Chief Executive Officer, Chief
Financial Officer and Director
|
|
|
KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned whose signature appears below
constitutes and appoints Russell H. Plumb and Michael A. Henos, his or her true and lawful
attorneys-in-fact, with full power of substitution and resubstitution for him or her and on his or
her behalf, and in his or her name, place and stead, in any and all capacities to execute and sign
any and all amendments or post-effective amendments to this registration statement, and to file the
same, with all exhibits thereto, and other documents in connection therewith, with the Securities
and Exchange Commission, hereby ratifying and confirming all that said attorneys-in-fact or any of
them or their or his substitute or substitutes, may lawfully do or cause to be done by virtue
hereof and the Company hereby confers like authority on its behalf.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been
signed below by the following persons in the capacity and on the dates indicated.
|
|
|
|
|
|
|
/s/ Russell H. Plumb
Russell H. Plumb
|
|
|
|
President, Chief Executive
Officer, Chief Financial Officer
and Director
(Principal Executive and
Principal Financial Officer)
|
|
July 1, 2010
|
|
|
|
|
|
|
|
/s/ Michael A. Henos
|
|
|
|
Chairman of the Board of Directors
|
|
July 1, 2010
|
|
|
|
|
|
|
|
Michael A. Henos
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ M. James Barrett
|
|
|
|
Director
|
|
July 1, 2010
|
|
|
|
|
|
|
|
M. James Barrett, Ph.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Gabriele M. Cerrone
|
|
|
|
Director
|
|
July 1, 2010
|
|
|
|
|
|
|
|
Gabriele M. Cerrone
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Chris McGuigan
|
|
|
|
Director
|
|
July 1, 2010
|
|
|
|
|
|
|
|
Chris McGuigan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Russell M. Medford
|
|
|
|
Director
|
|
July 1, 2010
|
|
|
|
|
|
|
|
Russell M. Medford, M.D., Ph.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Marc L. Preminger
|
|
|
|
Director
|
|
July 1, 2010
|
|
|
|
|
|
|
|
Marc L. Preminger
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ A. Keith Willard
|
|
|
|
Director
|
|
July 1, 2010
|
|
|
|
|
|
|
|
A. Keith Willard
|
|
|
|
|
|
|
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jul 2023 to Jul 2024